[The role of miRNA in kidney development].


Journal

Yi chuan = Hereditas
ISSN: 0253-9772
Titre abrégé: Yi Chuan
Pays: China
ID NLM: 9436478

Informations de publication

Date de publication:
20 Nov 2020
Historique:
entrez: 24 11 2020
pubmed: 25 11 2020
medline: 7 1 2021
Statut: ppublish

Résumé

MicroRNAs (miRNAs) are endogenous small non-coding RNAs (19-25 nucleotides) that negatively regulate gene expression at the post transcriptional level by binding to complementary target sequences in the target mRNA. miRNAs play an important role in a wide range of biological processes, including organ development. Recent studies have shown that some miRNAs are highly expressed in the kidney and are closely related to kidney development and diseases, suggesting that miRNAs are important regulators in kidney physiology and pathology. This review will focus on the research progress of miRNA in kidney development, and discuss the role of miRNAs in the occurrence and development of renal dysplasia, which will provide a reference for the diagnosis and research of diseases related to kidney development. MicroRNAs( miRNAs)是一类内源性小非编码RNA (约19~25个核苷酸),主要通过与靶mRNA中的互补靶序列结合,在转录后水平负调节基因表达。miRNA在包括器官发育在内的广泛生物过程中发挥着重要作用。最近研究表明,某些miRNA在肾脏高表达,并与肾脏发育及肾脏疾病密切相关,提示miRNA为肾脏生理学和病理学中的重要调节剂。本综述重点介绍了miRNA在肾脏发育调控中的研究进展,探讨了miRNA在肾脏异常发育的发生发展中起到的作用,为肾脏发育相关疾病的诊断和研究提供参考。.

Autres résumés

Type: Publisher (chi)
MicroRNAs( miRNAs)是一类内源性小非编码RNA (约19~25个核苷酸),主要通过与靶mRNA中的互补靶序列结合,在转录后水平负调节基因表达。miRNA在包括器官发育在内的广泛生物过程中发挥着重要作用。最近研究表明,某些miRNA在肾脏高表达,并与肾脏发育及肾脏疾病密切相关,提示miRNA为肾脏生理学和病理学中的重要调节剂。本综述重点介绍了miRNA在肾脏发育调控中的研究进展,探讨了miRNA在肾脏异常发育的发生发展中起到的作用,为肾脏发育相关疾病的诊断和研究提供参考。.

Identifiants

pubmed: 33229313
pii: 20-112
doi: 10.16288/j.yczz.20-112
doi:

Substances chimiques

MicroRNAs 0

Types de publication

Journal Article Review

Langues

chi

Sous-ensembles de citation

IM

Pagination

1062-1072

Auteurs

Xiao Qi Zhao (XQ)

Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.

Ying Ao (Y)

Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.

Hai Yun Chen (HY)

Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.

Hui Wang (H)

Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH